MediSpend and RLDatix Life Sciences, a subsidiary of RLDatix, announce a definitive agreement to merge, creating a new unified company at the forefront of life sciences innovation and compliance. The combined company currently serves over 300 pharmaceutical, biotech, and medical device companies worldwide. Backed by Five Arrows (the alternative assets arm of Rothschild & Co.), Susquehanna Growth Equity, TA Associates, and Nordic Capital, the new company brings together RLD Life Sciences’ expertise in providing services for pharmaceutical product development, commercialization, and distribution with robust compliance, and sales enablement alongside MediSpend’s best-in-class transparency, stakeholder engagement, and data solutions supporting both commercial and clinical stakeholders.
Read the full article: MediSpend and Life Sciences Subsidiary of RLDatix Merge to Form Leading Global Provider of Regulatory and Compliance SaaS Solutions for Life Sciences //
Source: https://www.prnewswire.com/news-releases/medispend-and-life-sciences-subsidiary-of-rldatix-merge-to-form-leading-global-provider-of-regulatory-and-compliance-saas-solutions-for-life-sciences-302542271.html